{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:44:43Z","timestamp":1790189083212,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009508","name":"Skaggs School of Pharmacy and Pharmaceutical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009508","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010174","name":"University of Colorado","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010174","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bmcl.2022.128732","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T13:47:11Z","timestamp":1649771231000},"page":"128732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (Mpro) inhibitors"],"prefix":"10.1016","volume":"66","author":[{"given":"Emily G.","family":"Hicks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie E.","family":"Kandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed N.","family":"Lampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.128732_b0005","unstructured":"(CDC) USCfDC. Provisional Counts for Coronavirus Disease 2019 (COVID-19); 202https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/covid19\/index.htm. Accessed 12\/05\/21 2021."},{"key":"10.1016\/j.bmcl.2022.128732_b0010","unstructured":"University JH. Johns Hopkins Coronavirus Resource Center; 2021. https:\/\/coronavirus.jhu.edu\/. Accessed 12\/04\/21 2021."},{"key":"10.1016\/j.bmcl.2022.128732_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.761887","article-title":"Coronavirus disease 2019: clinics, treatment, and prevention","volume":"12","author":"Burkert","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2022.128732_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260575","article-title":"Will Africans take COVID-19 vaccination?","volume":"16","author":"Anjorin","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2022.128732_b0025","first-page":"1","article-title":"Measuring vaccination willingness in response to COVID-19 using a multi-criteria-decision making method","author":"Sarwar","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.bmcl.2022.128732_b0030","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 Breakthrough Infections in Vaccinated Health Care Workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2022.128732_b0035","article-title":"COVID-19 breakthrough infections and transmission risk: real-world data analyses from germany's largest public health department (Cologne)","volume":"9","author":"Hsu","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.bmcl.2022.128732_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13337-020-00575-1","article-title":"Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019\u20132020","volume":"31","author":"Islam","year":"2020","journal-title":"Virusdisease"},{"key":"10.1016\/j.bmcl.2022.128732_b0045","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00264-020-04625-7","article-title":"Trials and tribulations: so many potential treatments, so few answers","volume":"44","author":"Gazendam","year":"2020","journal-title":"Int Orthop"},{"key":"10.1016\/j.bmcl.2022.128732_b0050","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.1c00409","article-title":"Perspectives on SARS-CoV-2 Main Protease Inhibitors","author":"Gao","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128732_b0055","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1038\/s41467-021-26239-2","article-title":"Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19","volume":"12","author":"Boras","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2022.128732_b0060","first-page":"3428","article-title":"Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target","volume":"39","author":"Kundu","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmcl.2022.128732_b0065","article-title":"Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays","author":"Ma","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmcl.2022.128732_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26216559","article-title":"Naturally available flavonoid aglycones as potential antiviral drug candidates against SARS-CoV-2","volume":"26","author":"Al-Karmalawy","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2022.128732_b0075","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.1c08060","article-title":"Discovery of Di- and trihaloacetamides as covalent SARS-CoV-2 main protease inhibitors with high target specificity","author":"Ma","year":"2021","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2022.128732_b0080","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/2211-5463.12875","article-title":"Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease","volume":"10","author":"Tsuji","year":"2020","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bmcl.2022.128732_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target","volume":"30","author":"Ullrich","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2022.128732_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/v13050839","article-title":"HIV Protease: Historical Perspective and Current Research","volume":"13","author":"Weber","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.bmcl.2022.128732_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111798","article-title":"Past HIV-1 medications and the current status of combined antiretroviral therapy options for HIV-1 patients","volume":"13","author":"Weichseldorfer","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bmcl.2022.128732_b0100","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jceh.2018.07.004","article-title":"New direct-acting antivirals for the treatment of patients with hepatitis c virus infection: a systematic review of randomized controlled trials","volume":"9","author":"Pecoraro","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.bmcl.2022.128732_b0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14656566.2019.1697674","article-title":"Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C","volume":"21","author":"Zappulo","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bmcl.2022.128732_b0110","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2147\/DDDT.S254754","article-title":"Danoprevir for the treatment of hepatitis C virus infection: design, development, and place in therapy","volume":"14","author":"Miao","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bmcl.2022.128732_b0115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2022.128732_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lwt.2021.112684","article-title":"Identification of lactoferrin-derived peptides as potential inhibitors against the main protease of SARS-CoV-2","volume":"154","author":"Zhao","year":"2022","journal-title":"Lebensm Wiss Technol"},{"key":"10.1016\/j.bmcl.2022.128732_b0125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00894-021-04963-2","article-title":"Phenylethanoid glycosides as a possible COVID-19 protease inhibitor: a virtual screening approach","volume":"27","author":"Bernardi","year":"2021","journal-title":"J Mol Model"},{"key":"10.1016\/j.bmcl.2022.128732_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104967","article-title":"De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations","volume":"139","author":"Arshia","year":"2021","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.bmcl.2022.128732_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111779","article-title":"Structural and biochemical analysis of the dual inhibition of MG-132 against SARS-CoV-2 main protease (Mpro\/3CLpro) and human cathepsin-L","volume":"22","author":"Costanzi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2022.128732_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26227016","article-title":"Synthesis, antimicrobial, anticancer, PASS, molecular docking, molecular dynamic simulations & pharmacokinetic predictions of some methyl \u03b2-D-galactopyranoside analogs","volume":"26","author":"Amin","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2022.128732_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040607","article-title":"SARS-CoV-2 M(pro): a potential target for peptidomimetics and small-molecule inhibitors","volume":"11","author":"Citarella","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmcl.2022.128732_b0150","article-title":"In silico analyses of major active constituents of Fingerroot (Boesenbergia rotunda) unveils inhibitory activities against SARS-CoV-2 main protease enzyme. Saudi","author":"Bahadur Gurung","year":"2021","journal-title":"J Biol Sci"},{"key":"10.1016\/j.bmcl.2022.128732_b0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13578-021-00720-3","article-title":"Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors","volume":"11","author":"Yan","year":"2021","journal-title":"Cell Biosci"},{"key":"10.1016\/j.bmcl.2022.128732_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245962","article-title":"A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease","volume":"16","author":"Baker","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2022.128732_b0165","article-title":"Drug repurposing approach against novel coronavirus disease (COVID-19) through virtual screening targeting SARS-CoV-2 main protease","volume":"10","author":"Chowdhury","year":"2020","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.bmcl.2022.128732_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/ph14030213","article-title":"Repurposing of some natural product isolates as SARS-COV-2 Main Protease inhibitors via in vitro cell free and cell-based antiviral assessments and molecular modeling approaches","volume":"14","author":"Abdallah","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bmcl.2022.128732_b0175","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1021\/bi400109d","article-title":"Elucidating a relationship between conformational sampling and drug resistance in HIV-1 protease","volume":"52","author":"de Vera","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2022.128732_b0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12977-020-00520-6","article-title":"Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors","volume":"17","author":"Bastys","year":"2020","journal-title":"Retrovirology"},{"key":"10.1016\/j.bmcl.2022.128732_b0185","first-page":"1333","article-title":"Combating susceptibility to drug resistance: lessons from HIV-1 protease","volume":"11","author":"King","year":"2004","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmcl.2022.128732_b0190","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/s41467-021-22362-2","article-title":"Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors","volume":"12","author":"Iketani","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2022.128732_b0195","article-title":"Discovery and mechanism of SARS-CoV-2 main protease inhibitors","author":"Huff","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128732_b0200","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1038\/ncomms4155","article-title":"Diversity-oriented synthesis as a tool for identifying new modulators of mitosis","volume":"5","author":"Ibbeson","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2022.128732_b0205","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrd.2018.53","article-title":"Chemical probes and drug leads from advances in synthetic planning and methodology","volume":"17","author":"Gerry","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2022.128732_b0210","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.chembiol.2019.02.018","article-title":"Cheminformatics tools for analyzing and designing optimized small-molecule collections and libraries","volume":"26","author":"Moret","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmcl.2022.128732_b0215","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.bmcl.2022.128732_b0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmcl.2022.128732_b0225","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s42003-020-0939-8","article-title":"Improved designs for pET expression plasmids increase protein production yield in Escherichia coli","volume":"3","author":"Shilling","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.bmcl.2022.128732_b0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.virusres.2007.02.015","article-title":"Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery","volume":"133","author":"Grum-Tokars","year":"2008","journal-title":"Virus Res"},{"key":"10.1016\/j.bmcl.2022.128732_b0235","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Autom Control"},{"key":"10.1016\/j.bmcl.2022.128732_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26196068","article-title":"Natural polyphenols inhibit the dimerization of the SARS-CoV-2 main protease: the case of fortunellin and its structural analogs","volume":"26","author":"Panagiotopoulos","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2022.128732_b0245","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02094-21","article-title":"Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300","volume":"12","author":"Davis","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.bmcl.2022.128732_b0250","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1128\/JVI.02680-07","article-title":"Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease","volume":"82","author":"Shi","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.bmcl.2022.128732_b0255","doi-asserted-by":"crossref","first-page":"25428","DOI":"10.1002\/anie.202109965","article-title":"NMR spectroscopy of the main protease of SARS-CoV-2 and fragment-based screening identify three protein hotspots and an antiviral fragment","volume":"60","author":"Cantrelle","year":"2021","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmcl.2022.128732_b0260","doi-asserted-by":"crossref","first-page":"15452","DOI":"10.1038\/s41598-021-94951-6","article-title":"Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 M(PRO)","volume":"11","author":"Jim\u00e9nez-Avalos","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2022.128732_b0265","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1016\/j.csbj.2021.11.016","article-title":"Novel dynamic residue network analysis approaches to study allosteric modulation: SARS-CoV-2 M(pro) and its evolutionary mutations as a case study","volume":"19","author":"Sheik Amamuddy","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.bmcl.2022.128732_b0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.bmcl.2022.128732_b0275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-2006-962735","article-title":"Barbaloin in aloe species","volume":"53","author":"Groom","year":"1987","journal-title":"Planta Med"},{"key":"10.1016\/j.bmcl.2022.128732_b0280","article-title":"The Genus Aloe Edited by T. Reynolds (Jodrell Laboratory, Royal Botanical Gardens, Kew). CRC Press, Boca Raton, FL. 2004. xvii + 386 pp. 7 \u00d7 10 1\/4 in. $119.95. ISBN 0-415-30672-8","volume":"68","author":"Aloes","year":"2005","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmcl.2022.128732_b0285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000200705","article-title":"A double-blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation","volume":"49","author":"Odes","year":"1991","journal-title":"Digestion"},{"key":"10.1016\/j.bmcl.2022.128732_b0290","doi-asserted-by":"crossref","first-page":"559","DOI":"10.7547\/87507315-79-11-559","article-title":"Wound healing. Oral and topical activity of Aloe vera","volume":"79","author":"Davis","year":"1989","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.bmcl.2022.128732_b0295","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/14756366.2016.1235568","article-title":"Tyrosinase inhibitory components from Aloe vera and their antiviral activity","volume":"32","author":"Kim","year":"2017","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2022.128732_b0300","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1248\/cpb.50.309","article-title":"Mushroom tyrosinase inhibition activity of some chromones","volume":"50","author":"Piao","year":"2002","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.bmcl.2022.128732_b0305","doi-asserted-by":"crossref","first-page":"19506","DOI":"10.1021\/acsomega.0c01775","article-title":"Anti-inflammatory, antinociceptive, and antioxidant properties of anacardic acid in experimental models","volume":"5","author":"Gomes J\u00fanior","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmcl.2022.128732_b0310","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.chembiol.2021.04.020","article-title":"Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2","volume":"28","author":"Shan","year":"2021","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmcl.2022.128732_b0315","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.envint.2015.09.011","article-title":"Biomonitoring of human exposures to chlorinated derivatives and structural analogs of bisphenol A","volume":"85","author":"Andra","year":"2015","journal-title":"Environ Int"},{"key":"10.1016\/j.bmcl.2022.128732_b0320","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22002086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22002086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:45:00Z","timestamp":1760773500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22002086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":64,"alternative-id":["S0960894X22002086"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128732","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (Mpro) inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128732"}}